MAZEMaze Therapeutics Inc.
Slide 1 of 3
Company Overview
Name
Maze Therapeutics Inc.
52W High
$36.50
52W Low
$6.71
Market Cap
$1.6B
Dividend Yield
0%
Price/earnings
-0.66
P/E
-0.66
Tags
Dividends
No dividend
Sentiment
Score
Bullish
75
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 2 of 3
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
$-33M
Net Income
$-30.1M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$4.29
Price to Earnings
$0.00
Additional Data
Selling, General & Admin Expense
$7.8M
Research & Development Expense
$25.2M
Total Operating Expenses
$-33M
Interest & Investment Income
$2.9M
Other Income / (Expense), net
N/A
Total Other Income / (Expense), net
$2.9M
Slide 3 of 3
Earnings History
Estimated EPS
Reported EPS
N/A Slide 1 of 5
Company Overview
Name
Maze Therapeutics Inc.
52W High
$36.50
52W Low
$6.71
Market Cap
$1.6B
Dividend Yield
0%
Price/earnings
-0.66
P/E
-0.66
Tags
Dividends
No dividend
Slide 2 of 5
Sentiment
Score
Bullish
75
Low
Neutral
High
0
50
100
Trade Volume
Score
Neutral
50
Low
Neutral
High
0
50
100
Slide 3 of 5
Income Statement
Total Revenue
Operating Revenue
Total Gross Profit
Total Operating Income
$-33M
Net Income
$-30.1M
EV to EBITDA
$0.00
EV to Revenue
$0.00
Price to Book value
$4.29
Price to Earnings
$0.00
Slide 4 of 5
Additional Data
Selling, General & Admin Expense
$7.8M
Research & Development Expense
$25.2M
Total Operating Expenses
$-33M
Interest & Investment Income
$2.9M
Other Income / (Expense), net
N/A
Total Other Income / (Expense), net
$2.9M
Slide 5 of 5
Earnings History
Estimated EPS
Reported EPS
N/AUpcoming Earnings
We were not able to find an announced earnings date for this symbol yet. Check back again later
Company Info
CEO
Jason Coloma
Location
California, USA
Exchange
Nasdaq
Website
https://mazetx.com
Summary
We are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity.
Company Info
CEO
Jason Coloma
Location
California, USA
Exchange
Nasdaq
Website
https://mazetx.com
Summary
We are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity.
